CVRx Garners $29,600,000 New Financing Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=5dc07084-fca9-4bb9-877f-1470fe7bc531 - Date
7/11/2013 - Company Name
CVRx - Mailing Address
9201 West Broadway Avenue Minneapolis, MN 55445 - Company Description
The company has developed proprietary technology for the treatment of high blood pressure, also referred to as hypertension, that cannot be controlled with medications (refractory or resistant hypertension). - Website
http://www.cvrx.com - Transaction Type
Venture Equity - Transaction Amount
$29,600,000 - Transaction Round
Undisclosed - Proceeds Purposes
CVRx plans to use the funding for the primary purposes of advancing its clinical trials and expanding its international commercial activities. - M&A Terms
- Venture Investor
New Enterprise Associates - Venture Investor
Johnson & Johnson Development Corporation - Venture Investor
BBT Fund - Venture Investor
SightLine Partners
